Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock?

Obesity and nonalcoholic fatty liver disease (NAFLD) constitute global and growing epidemics that result in therapeutic dead ends. There is an urgent need for new and accessible treatments to improve and widen both preventive and curative approaches against NAFLD. The endocannabinoid system (ECS) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Barré, Tangui, Di Marzo, Vincenzo, Marcellin, Fabienne, Burra, Patrizia, Carrieri, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942183/
https://www.ncbi.nlm.nih.gov/pubmed/35420457
http://dx.doi.org/10.1089/can.2022.0014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942183/
https://www.ncbi.nlm.nih.gov/pubmed/35420457
http://dx.doi.org/10.1089/can.2022.0014

Ejemplares similares